Irritable bowel syndrome: A systematic review

Clinics in Family Practice

Volumn 6, Issue 3, 2004, Pages 647-669

  Cash, Brooks D ^a   Chey, William D ^b,c  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; ANTIDIARRHEAL AGENT; BULKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CASCARA; CHOLINERGIC RECEPTOR BLOCKING AGENT; COLESTYRAMINE; COLOFAC; DESIPRAMINE; DICYCLOVERINE; DIPHENOXYLATE; FLUOXETINE; GRANISETRON; HYOSCYAMINE; ISPAGULA; LOPERAMIDE; MUSCARINIC RECEPTOR BLOCKING AGENT; ONDANSETRON; OPIATE DERIVATIVE; PAROXETINE; PEPPERMINT OIL; PLACEBO; SENNA EXTRACT; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SPASMOLYTIC AGENT; TEGASEROD; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

ABDOMINAL PAIN; AUTONOMIC NERVOUS SYSTEM; BEHAVIOR THERAPY; CELIAC DISEASE; CLINICAL FEATURE; CLINICAL STUDY; CLINICAL TRIAL; CONSTIPATION; DIAGNOSTIC PROCEDURE; DIARRHEA; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DOCTOR PATIENT RELATION; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG EFFICACY; DRUG FATALITY; DRUG PENETRATION; EMOTIONAL STRESS; EVIDENCE BASED MEDICINE; EXPERIMENTAL DESIGN; FECES IMPACTION; GASTROINTESTINAL INFECTION; GENETIC PREDISPOSITION; HUMAN; INTESTINE INNERVATION; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; IRRITABLE COLON; ISCHEMIC COLITIS; PATHOPHYSIOLOGY; PATIENT EDUCATION; PRACTICE GUIDELINE; PREVALENCE; PSYCHOTHERAPY; REVIEW; RISK FACTOR; SCREENING; SENSATION; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TOXIC MEGACOLON; VALIDATION PROCESS;

EID: 4344561707     PISSN: 15225720     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cfp.2004.03.010     Document Type: Review

References (100)

1. Longstreth G.F. Wolde-Tsadik G. Irritable bowel-type symptoms in HMO examinees: prevalence, demographics and clinical correlates Dig Dis Sci 38 1993 1581-1589
2. Mitchell C.M. Drossman D.A. Survey of the AGA membership relating to patients with functional gastrointestinal disorders Gastroenterology 92 1987 1282-1284
3. Drossman D.A. Whitehead W.E. Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development Gastroenterology 112 1997 2120-2137
4. Drossman D.A. Thompson W.G. The irritable bowel syndrome: review and a graduated, multicomponent treatment approach Ann Intern Med 116 1992 1009-1016
5. Sandler R.S. Epidemiology of irritable bowel syndrome in the United States Gastroenterology 99 1990 409-415
6. Gralnek I.M. Hays R.D. Kilbourne A. et al. The impact of irritable bowel syndrome on health-related quality of life Gastroenterology 119 2000 654-660
7. Drossman D.A. Li Z. Andruzzi E. et al. US householder survey of functional GI disorders: prevalence, sociodemography, and health impact Dig Dis Sci 38 1993 1569-1580
8. Leong S.A. Barghout V. Birnbaum H.G. et al. The economic consequences of irritable bowel syndrome. A US employer perspective Arch Intern Med 163 2003 929-935
9. American Gastroenterological Association The burden of gastrointestinal diseases 2001 American Gastroenterological Association Bethesda (MD)
10. Hasler W.L. Schoenfeld P. Systematic review: abdominal and pelvic surgery in patients with irritable bowel syndrome Aliment Pharmacol Ther 17 8 2003 997-1005
11. Martin R. Barron J.J. Zacker C. Irritable bowel syndrome: toward a cost-effective management approach Am J Manag Care 7 Suppl 8 2001 S268-S275
12. Camilleri M. Williams D.E. Economic burden of irritable bowel syndrome Lancet 340 1992 1447-1452
13. Camilleri M. Atanasova E. Carlson P.J. et al. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome Gastroenterology 123 2 2002 425-432
14. Locke G.R.III Zinsmeister A.R. Talley N.J. et al. Familial association in adults with functional gastrointestinal disorders Mayo Clin Proc 75 9 2000 907-912
15. Kalantar J.S. Locke G.R. III Talley N.J. et al. Is irritable bowel syndrome more likely to be persistent in those with relatives who suffer from gastrointestinal symptoms? A population-based study at three time points Aliment Pharmacol Ther 17 11 2003 1389-1397
16. Levy R.L. Jones K.R. Whitehead W.E. et al. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology Gastroenterology 121 4 2001 799-804
17. Bazocchi G. Ellis J. Villaneuva-Meyer J. et al. Colonic scintigraphy and manometry in constipation, diarrhea, and inflammatory bowel disease [abstract] Gastroenterology 94 1988 A29
18. Cann P.A. Read N.W. Brown C. et al. Irritable bowel syndrome. Relationship of disorders in the transit of a single solid meal to symptom patterns Gut 24 1983 405-411
19. Vassallo M. Camilleri M. Phillips S.F. et al. Transit through the proximal colon influences stool weight in the irritable bowel syndrome Gastroenterology 102 1992 102-108
20. Bazocchi G. Ellis J. Villaneuva-Meyer J. et al. Postprandial colonic transit and motor activity in chronic constipation Gastroenterology 98 1990 686-693
21. Naliboff B.D. Derbyshire S.W.G. Munakata J. et al. Cerebral activation in irritable bowel syndrome patients and control subjects during rectosigmoid stimulation Psychosom Med 63 2001 365-375
22. Mertz H. Morgan V. Tanner G. et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention Gastroenterol 118 2000 842-848
23. Wood J.D. Enteric nervous system, serotonin and the irritable bowel syndrome Curr Opin Gastroenterol 17 2001 91-97
24. Spiller R.C. Postinfectious irritable bowel syndrome Gastroenterol 124 2003 1662-1671
25. Dickhaus B. Mayer E.A. Firooz N. et al. Irritable bowel syndrome patients show enhanced modulation of visceral perception by auditory stress Am J Gastroenterol 98 2003 135-143
26. Drossman D.A. Lesserman J. Nachman G. et al. Sexual and physical abuse in women with functional or organic gastrointestinal disorders Ann Intern Med 113 1990 828-833
27. Walker E.A. Gelfand A.N. Gelfand M.D. et al. Medical and psychiatric symptoms in female gastroenterology clinic patients with histories of sexual victimization Gen Hosp Psychiatry 17 1995 85-92
28. Lesserman J. Drossman D.A. Li Z. et al. Sexual and physical abuse history in gastroenterology practice: how types of abuse impact health status Psychosom Med 58 1996 4-15
29. Miller A.R. North C.S. Clouse R.E. et al. The association of irritable bowel syndrome and somatization disorder Ann Clin Psychiatry 13 2001 25-30
30. Whitehead W.E. Palsson O. Jones K.R. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 122 2002 1140-1156
31. Jackson J.L. O'Malley P.G. Tomkins G. et al. Treatment of functional bowel gastrointestinal disorders with antidepressant medications: a meta-analysis Am J Med 108 2000 65-72
32. Cash B.D. Chey W.D. Irritable bowel syndrome: an evidence-based management approach Journal of Clinical Outcomes Management 9 7 2002 409-418
33. Manning A.P. Thompson W.G. Heaton K.W. et al. Towards a positive diagnosis of the irritable bowel syndrome BMJ 2 1978 653-654
34. Thompson W.G. Doteval G. Drossman D.A. et al. Irritable bowel syndrome: guidelines for the diagnosis Gastroenterology International 2 1989 92-95
35. Thompson W.G. Longstreth G.F. Drossman D.A. et al. Functional bowel disorders and functional abdominal pain Gut 45 Suppl 2 1999 43-47
36. Brandt L.J. Locke R. Olden K. et al. An evidence based approach to the diagnosis of irritable bowel syndrome in North America Am J Gastroenterol 97 Suppl 11 2002 S1-S26
37. Drossman D.A. Camilleri M. Mayer E.A. et al. AGA technical review on irritable bowel syndrome Gastroenterology 123 2002 2108-2131
38. Vanner S.J. Depew W.T. Paterson W.G. et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome Am J Gastroenterol 94 1999 2912-2917
39. Chey W.D. Olden K. Carter E. et al. Utility of the Rome I and Rome II criteria for IBS in US women Am J Gastroenterol 97 2002 2803-2811
40. Drossman D.A. An integrated approach to the irritable bowel syndrome Aliment Pharmacol Ther 13 Suppl 2 1999 3-14
41. Camilleri M. Prather C.M. The irritable bowel syndrome: mechanisms and a practical approach to management Ann Intern Med 116 1992 1001-1008
42. American Gastroenterological Association American Gastroenterological Association medical position statement: irritable bowel syndrome Gastroenterology 123 2002 2105-2107
43. Cash B.D. Schoenfeld P.S. Chey W.D. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review Am J Gastroenterol 97 2002 2812-2819
44. Lijmer J.G. Mol B.W. Heisterkamp S. et al. Empirical evidence of design-related bias in studies of diagnostic tests JAMA 282 1999 1061-1066
45. Hamm L.R. Sorrells S.C. Harding J.P. et al. Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria Am J Gastroenterol 94 1999 1279-1282
46. Tolliver B.A. Herrera J.L. DiPalma J.A. Evaluation of patients who meet clinical criteria for irritable bowel syndrome Am J Gastroenterol 89 1994 176-178
47. MacIntosh D.G. Thompson W.G. Patel D.G. et al. Is rectal biopsy necessary in irritable bowel syndrome? Am J Gastroenterol 87 1992 1407-1409
48. Francis C.Y. Duffy J.N. Whorwell P.J. et al. Does routine ultrasound enhance diagnostic accuracy in irritable bowel syndrome? Am J Gastroenterol 91 1996 1348-1350
49. Sanders D.S. Carter M.J. Hurlstone D.P. et al. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling the ROME II criteria referred to secondary care Lancet 358 2001 1504-1508
50. Pimentel M. Chow E.J. Lin H.C. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome Am J Gastroenterol 95 2000 3503-3506
51. 2-blocker therapy or prompt endoscopy in management of dyspepsia Lancet 343 1994 811-816
52. Lassen A.T. Pedersen F.M. Bytzer P. et al. Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial Lancet 356 9228 2000 455-460
53. Carin P.A. Read N.W. Holdsworth C.D. What is the benefit of coarse wheat bran in patients with irritable bowel syndrome? Gut 24 1984 168-173
54. Arffman S. Anderson J.R. Hegnhoj J. et al. The effect of coarse wheat bran in the irritable bowel syndrome. A double blind cross-over study Scand J Gastroenterol 20 1985 295-298
55. Lucey M.R. Clark M.L. Lowndes J.O. et al. Is bran efficacious in irritable bowel syndrome? A double-blind placebo controlled cross-over study Gut 28 1987 221-225
56. Niec A.M. Frankum B. Talley N.J. Are adverse food reactions linked to irritable bowel syndrome? Am J Gastroenterol 93 1998 2184-2190
57. Brandt L.J. Locke G.R. Olden K. et al. An evidence-based approach to the management of irritable bowel syndrome in North America. American College of Gastroenterology Functional Gastrointestinal Disorders Task Force Am J Gastroenterol 97 Suppl 11 2002 S1-S26
58. Schoenfeld P. Chey W.D. An evidence-based approach to clinical practice guidelines: diagnosis and treatment of irritable bowel syndrome Clin Gastroenterol Hepatol 1 2003 322-327
59. Creed F. Fernandes L. Guthrie E. et al. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome Gastroenterology 124 2003 303-317
60. Drossman D.A. Toner B.B. Whitehead W.E. et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders Gastroenterology 125 2003 19-31
61. Cann P.A. Read N.W. Holdsworth C.D. et al. Role of loperamide and placebo in management of irritable bowel syndrome (IBS) Dig Dis Sci 29 1984 239-247
62. Hovdenak N. Lopermide treatment of the irritable bowel syndrome Scand J Gastroenterol Suppl 130 1987 81-84
63. Efskind P.S. Bernklev T. Vatn M.H. A double-blind, placebo controlled trial with loperamide in irritable bowel syndrome Scand J Gastroenterol 31 1996 463-468
64. Poynard T. Naveau S. Mory B. et al. Meta-analysis of smooth muscle relaxers in the treatment of irritable bowel syndrome Aliment Pharmacol Ther 8 1994 499-510
65. Jaiwala J. Imperiale T.F. Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials Ann Intern Med 133 2000 136-147
66. Pittler M.H. Ernst E. Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis Am J Gastroenterol 93 1998 1131-1135
67. Wheatley D. Irritable colon syndrome treated with an antispasmodic drug Practitioner 217 1976 276-280
68. Page J. Dirnberger G.M. Treatment of the irritable bowel syndrome with bentyl (dicyclomine hydrochloride) J Clin Gastroenterol 3 1981 153-156
69. Ritchie J.A. Truelove S.C. Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk BMJ 10 1979 376-378
70. Clouse R.E. Antidepressants for irritable bowel syndrome Gut 52 2003 598-599
71. Akehurst R. Kaltenthaler E. Treatment of irritable bowel syndrome: a review of randomised controlled trials Gut 48 2001 272-282
72. Creed F.H. Joy R. Guthrie E.A. Cost-effective randomised controlled trial of psychotherapy and antidepressants for severe irritable bowel syndrome Psychosom Med 62 2000 108-109
73. Clouse R.E. Antidepressants for functional gastrointestinal syndromes Dig Dis Sci 39 11 1994 2352-2363
74. Chial H.J. Camilleri M. Ferber I. et al. Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans Clin Gastroenterol Hepatol 1 2003 211-218
75. Kuiken S.D. Tytgat G.N.J. Boeckxstaens G.E.E. The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study Clin Gastroenterol Hepatol 1 2003 219-228
76. Gershon M. Roles played by 5-hydroxytryptamine in the physiology of the bowel Aliment Pharmacol Ther 13 1999 15-30
77. Camilleri M. Chey W.Y. Mayer E.A. et al. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome Arch Intern Med 161 2001 1733-1740
78. 3 receptor antagonist Aliment Pharmacol Ther 13 1999 1149-1151
79. Camilleri M. Northcutt A.R. Kong S. et al. The efficacy and safety of alosetron in female patients with irritable bowel syndrome: a randomized, placebo controlled study Lancet 355 2000 1035-1040
80. Lembo T. Wright R.A. Bagby B. et al. Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome Am J Gastroenterol 96 2001 2662-2670
81. Jones R. Holmann G. Rodrigo L. et al. Alosetron relieves pain and improves bowel function compared with mebeverine in female non-constipated irritable bowel syndrome patients Aliment Pharmacol Ther 13 1999 1419-1427
82. Olden K. DeGarmo R.G. Jhingran P. et al. Patient satisfaction with alosetron for the treatment of women with diarrhea-predominant irritable bowel syndrome Am J Gastroe nterol 97 2002 3139-3146
83. Lotronex tablets: understanding the risks and benefits 2002 GlaxoSmithKline, USA Research Triangle Park (NC)
84. Camilleri M. Review article: tegaserod Aliment Pharmacol Ther 15 2001 277-289
85. 4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation Aliment Pharmacol Ther 15 2001 1655-1656
86. Whorwell P.J. Krumholz S. Muller-Lisner S. et al. Tegaserod has a favorable safety and tolerability profile in patients with constipation-predominant irritable bowel syndrome Gastroenterology 118 2000 A1204
87. Novick J. Miner P. Krause R. et al. A randomized, double-blind, placebo controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation Aliment Pharmacol Ther 16 2002 877-878
88. Kellow J. Lee O.Y. Chang F.Y. et al. An Asia-Pacific, double blind, placebo controlled, randomized study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome Gut 52 2003 671-676
89. Tougas G. Snape W.J. Jr. Otten M.H. et al. Long-term safety of tegaserod in patients with constipation-predominant irritable bowel syndrome Aliment Pharmacol Ther 16 2002 1701-1708
90. Palsson O.S. Turner M.J. Johnson D.A. et al. Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms Dig Dis Sci 47 2002 2605-2614
91. Gonsalkorale W.M. Houghton L.A. Whorwell P.J. Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness Am J Gastroenterol 97 2002 954-961
92. Keefer L. Blanchard E.B. A one-year follow-up of relaxation response meditation as a treatment for irritable bowel syndrome Behav Res Ther 40 2002 541-546
93. Smart H.L. Mayberry J.F. Atkinson M. Alternative medicine consultations and remedies in patients with the irritable bowel syndrome Gut 27 7 1986 826-828
94. Koloski N.A. Talley N.J. Huskic S.S. et al. Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia Aliment Pharmacol Ther 17 6 2003 841-851
95. Li Y. Tougas G. Chiverton S.G. et al. The effect of acupuncture on gastrointestinal function and disorders Am J Gastroenterol 87 1992 1372-1381
96. Chan J. Carr I. Mayberry J.F. The role of acupuncture in the treatment of irritable bowel syndrome: a pilot study Hepatogastroenterology 44 1997 1328-1330
97. Niedzielin K. Kordecki H. Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome Eur J Gastroenterol Hepatol 13 10 2001 1143-1147
98. Nobaek S. Johansson M.L. Molin G. et al. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome Am J Gastroenterol 95 5 2000 1231-1238
99. Kim H.J. Camilleri M. McKinzie S. et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome Aliment Pharmacol Ther 17 7 2003 895-904
100. Bensoussan A. Talley N. Hing M. et al. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial JAMA 280 18 1998 1585-1589